For instance, hydrophobic lysosomotropic agents that trigger lysosomal membrane permeabilization may enhance tumor cell death, whereas non–cell-permeable cathepsin inhibitors can selectively attenuate the invasive and metastatic potential of tumor cells in vivo [31]. This evidence concerns the gene CTSS and neoplasm.